How to Document Substance Abuse and Addiction Counseling Sessions

A practical guide for addiction counselors, social workers, and therapists on writing progress notes that hold up to audits, support continuity of care, and capture the clinical complexity of SUD treatment.

Documenting substance use disorder (SUD) treatment is different from documenting a standard outpatient therapy session. The same progress note you would write for a client working through anxiety or relationship conflict will not capture what insurance reviewers, probation officers, prescribing physicians, or multidisciplinary team members need to see in an addiction treatment record.

SUD documentation carries more legal exposure, more regulatory complexity, and more clinical nuance than almost any other specialty. A client may be mandated by a court, ambivalent about being in your office, in active withdrawal, or simultaneously enrolled in medication-assisted treatment (MAT) managed by a separate provider. Your note is often the thread that holds those clinical relationships together.

This guide covers the documentation practices that actually matter in addiction counseling: ASAM placement criteria, treatment plan elements unique to SUD, group therapy notes, MAT coordination, court-ordered treatment records, urine drug screen (UDS) documentation, motivational stage tracking, and how to write a progress note that a covering clinician or auditor can actually use.

Why SUD Documentation Is Its Own Category

Most clinical documentation guides treat SUD as a subset of mental health. That is a mistake. SUD treatment has its own placement criteria, its own regulatory framework (42 CFR Part 2 governs confidentiality of substance use records in the US, which is stricter than general medical confidentiality), its own billing codes, and its own ecosystem of external stakeholders who may have legitimate access to some but not all of your records.

Every SUD note you write should account for three audiences simultaneously: the clinical team responsible for care, the payer or authorization reviewer, and the legal or oversight system (if applicable). Generic progress notes serve none of them well.

ASAM Criteria Documentation

The American Society of Addiction Medicine (ASAM) Criteria is the most widely used framework for determining the appropriate level of care for SUD clients. Most payers, managed care organizations, and state licensing bodies expect documentation to reflect ASAM placement logic, even in outpatient settings.

ASAM organizes clinical assessment across six dimensions:

Acute intoxication and/or withdrawal potential
Biomedical conditions and complications
Emotional, behavioral, or cognitive conditions and complications
Readiness to change
Relapse, continued use, or continued problem potential
Recovery and living environment

Your intake assessment, treatment plan, and periodic reviews should reflect findings in each relevant dimension. You do not need to label every section "ASAM Dimension 1" explicitly, but the content needs to be there. An auditor looking at your record should be able to reconstruct your placement rationale from what you wrote.

Fictional example (intake note excerpt):

Marcus T., 34, presenting for outpatient SUD evaluation. No acute withdrawal symptoms observed at time of session; client reports last alcohol use 36 hours ago, 8-10 standard drinks daily for the past 3 years. Hypertension managed by PCP, no liver disease noted in client-reported history. Client endorses moderate anxiety, denies current SI/HI. Ambivalent about treatment; attended today due to pressure from spouse. Reports multiple prior quit attempts, longest sobriety 4 months. Currently employed, residing with spouse and two children; family described as supportive conditional on sobriety. Placed at ASAM Level 1 (Outpatient) with CIWA-Ar score of 4 at intake; will reassess in 48 hours if client reports worsening withdrawal.

This note documents all six ASAM dimensions without using the formal headings. The placement decision is inferable from the content, which is what reviewers actually look for.

Treatment Plan Elements Specific to SUD

Standard treatment plan components (presenting problem, goals, objectives, interventions, review date) apply in SUD settings, but the content of each element needs to reflect addiction-specific clinical concepts.

Relapse Prevention Planning

Every SUD treatment plan should include a relapse prevention plan as a named, discrete component. This is not the same as a general coping skills goal. A relapse prevention plan identifies:

High-risk situations (people, places, emotional states, times of day)
Triggers specific to the client's use pattern
Coping strategies tied to those specific triggers
Early warning signs the client and clinician have agreed to monitor
A crisis response protocol if relapse occurs

Document what the client actually said, not what the template says. A relapse prevention plan that reads like it was copied from a textbook will not hold up in a continuing care authorization review.

Fictional example (treatment plan excerpt):

Relapse Prevention Plan: Client identifies Friday evenings after work as highest-risk period, citing habit of stopping at bar with coworkers. Identified triggers include workplace stress, feeling "invisible" in meetings, and isolation on weekends. Agreed-upon coping strategies: contact sponsor before Friday workday ends, plan alternative Friday evening activity, attend Saturday morning AA meeting as anchor. Early warning signs identified by client: increased irritability on Thursday/Friday, skipping gym more than twice in a week, and withdrawing from spouse. If relapse occurs: contact counselor by phone within 24 hours, attend next available group session, review plan together before next individual session.

Motivational Stage Tracking

Motivational Interviewing (MI) and the Transtheoretical Model (TTM) of change are both standard frameworks in addiction counseling. Your notes should reflect where the client sits in the change process, how that changed session to session, and what interventions you used to support movement.

Document the motivational stage (precontemplation, contemplation, preparation, action, maintenance) at each session and note evidence for your assessment. Do not simply write "client is in contemplation stage." Write what the client said that supports that assessment.

Fictional example (progress note excerpt):

Client arrived on time, appeared slightly guarded. Reports no alcohol use since last session (7 days), though notes "I'm not sure I actually have a problem, my wife thinks I do." Motivational stage assessed as contemplation: client acknowledges concerns raised by spouse and recent blackout episode but continues to express ambivalence about whether abstinence is necessary. Used reflective listening and decisional balancing. Client identified two benefits of continued use ("relaxes me, helps me sleep") and three significant costs ("my kids don't trust me, I missed work twice, the DUI"). Agreed to track urges and what preceded them this week using provided worksheet.

This gives any covering clinician a precise picture of where the client is and what happened in the session.

Documenting Group Therapy in Addiction Settings

Group therapy is the backbone of most IOP (intensive outpatient program) and PHP (partial hospitalization program) addiction treatment. Documenting group sessions correctly is one of the most consistently mishandled areas in SUD records.

The most important rule: individual group progress notes are required for each client. A single group note filed for all members does not meet most payer requirements and creates serious liability exposure. Every client needs their own note that documents their individual participation, presentation, and clinical status during that session.

A group session note for a SUD client should include:

Group topic or module (e.g., "Relapse Prevention: Managing Social Triggers")
Client's level of engagement (active participant, observer, withdrawn)
Specific contributions or responses the client made that are clinically relevant
Behavioral observations (mood, affect, appearance, any concerning statements)
How group content connects to the client's individual treatment plan goals
Any follow-up indicated

Fictional example (group note):

Group topic: Anger and substance use (CBT module 4). Attendance: 8 members present. Denise P. arrived on time, appeared dysphoric. Participated when called on but did not initiate comments. When discussing the connection between anger and drinking, client stated "I drink when I'm mad because it's the only thing that works." This statement was explored briefly in group with client's permission; she identified three recent anger episodes that preceded use. Plan: expand exploration of anger-to-use cycle in individual session next week. No safety concerns noted. Client denied use since last session.

What this note does not include: other group members' names, statements, or clinical information. Confidentiality within group settings is a real clinical and ethical issue in SUD treatment, and your notes should reflect that discipline.

Medication-Assisted Treatment (MAT) Documentation

Medication-assisted treatment (MAT) uses FDA-approved medications (buprenorphine, methadone, naltrexone) in combination with counseling to treat opioid use disorder (OUD) and alcohol use disorder (AUD). If your client is on MAT, your documentation must reflect that, even if you are not the prescribing provider.

Your counseling notes should document:

That the client is enrolled in MAT and the prescribing provider's name and contact
Client's reported adherence and any concerns about medication (side effects, missed doses, diversion concerns)
How the MAT is interacting with the client's counseling goals and recovery progress
Any communication you have had with the prescribing provider, including the date, format, and content of that communication

Fictional example (MAT coordination note):

Client reports taking buprenorphine/naloxone 8mg/2mg daily as prescribed by Dr. Rivera at Community Health Partners. Reports no missed doses. Denies diversion. States medication has "quieted the cravings," which has allowed him to focus more in sessions. No side effects reported beyond mild constipation (discussed with prescriber last week per client report). Coordinated with Dr. Rivera via secure message 03/20/2026 re: client's reported increase in cannabis use as a potential substitution concern; awaiting response. Note filed in coordination log.

If a prescriber, insurance auditor, or licensing board ever reviews this record, they can see that you are functioning as part of a coordinated team rather than in isolation.

Court-Ordered Treatment Documentation

Court-ordered treatment introduces a different set of documentation requirements. Clients in this situation are often mandated to attend, may be explicitly ambivalent or resistant, and have legal stakeholders who require periodic compliance reports.

Document the following in every session with a mandated client:

The referral source (court, probation officer, attorney) and the terms of the mandate (how many sessions, what reporting is required, what constitutes compliance)
Attendance and punctuality, because compliance reporting depends on it
The client's engagement level, noted factually and without punitive framing
Whether any required reporting was completed this session (e.g., a signature on a court-required attendance form)
Any disclosures that affect the legal proceeding (with careful attention to what your consent forms and applicable law permit you to share)

A note on tone: Mandated clients will often say things in session that reflect their ambivalence about being there. Document what the client said factually. Avoid characterizations like "client was hostile" or "client was uncooperative" unless you can support those words with specific observed behaviors. Write "Client stated, 'I don't think I have a problem and I'm only here because the judge said I had to be'" rather than "Client was resistant and minimizing."

This protects you, protects the client, and produces a record that a probation officer or judge can interpret accurately.

Limits of Confidentiality in Mandated Settings

Be explicit in your notes about what was communicated to the referring legal authority and why. If you submitted a compliance report, attach a copy or note the date and content. If you are required to report a positive UDS to a probation officer, document that you did so and what information was shared.

42 CFR Part 2 (in the US) restricts what SUD treatment records can be disclosed without specific written consent, even to courts. Your consent forms and record-keeping practices need to reflect these rules. When in doubt, consult with a supervisor or legal advisor before disclosing.

Urine Drug Screen (UDS) Results in Progress Notes

Urine drug screen (UDS) results are clinical data points, not judgment calls. Document them as data.

For each UDS documented in a session note:

Note the date the screen was administered and whether it was observed or unobserved
List the substances tested and results (positive or negative for each panel)
If a result is unexpected (positive for a non-prescribed substance, or negative when the client is on buprenorphine), document that you discussed it with the client
Record the client's explanation, if any, and your clinical assessment of that explanation
Document what, if any, clinical action was taken in response to the result

Fictional example (UDS documentation):

UDS administered in office, unobserved, on 03/25/2026. Panel results: negative for opioids, benzodiazepines, cocaine, amphetamines. Positive for cannabinoids. Client reports using cannabis "a few times this week" to manage sleep, denies use of other substances. Cannabis use discussed in context of client's recovery goals and the IOP's substance use policy. Client states she does not consider cannabis use a setback. Explored ambivalence around cannabis use and its potential impact on overall recovery. No change to treatment plan at this time; will reassess at next session. Per program policy, result shared with clinical supervisor.

Avoid phrases like "client failed drug screen." Clients are not failing or passing. A positive result is a clinical data point that informs your treatment approach.

Writing Progress Notes That Support Continuity of Care

SUD treatment rarely involves a single provider. Your client may be seen by a counselor, a psychiatrist, a prescribing nurse practitioner, a case manager, a peer support specialist, and a primary care physician. Your notes are the primary mechanism by which those providers understand what is happening clinically.

A progress note that supports continuity of care includes:

A concise summary of the client's presentation at the start of the session (not just "client reports doing well")
What intervention you used and why, with enough specificity that another clinician could understand your clinical reasoning
The client's response to the intervention during the session
Any changes in clinical status (new disclosures, changes in substance use pattern, safety concerns)
Your assessment of progress toward treatment plan goals
A specific plan for the next session, including any referrals, coordination tasks, or homework assigned

The test: Can a clinician who has never met your client read this note and walk into the next session with a reasonable understanding of where the client is and what needs to happen? If the answer is no, the note is not doing its job.

Tools like NotuDocs can help you structure SUD notes using your own templates so that every required element appears consistently across sessions. The template-first approach is particularly useful in SUD settings where note elements (UDS results, motivational stage, relapse prevention plan updates) must appear reliably session after session.

Documenting Clients Who Are in Crisis

Clients in active SUD treatment are at elevated risk for overdose, self-harm, and suicide. When a session involves acute safety concerns, your documentation needs to reflect the clinical assessment and the response with specificity.

Document:

The specific statements or behaviors that indicated a crisis or elevated risk
The risk assessment you conducted, including the factors you considered (access to means, plan, intent, history, protective factors)
Interventions taken during the session (crisis plan review, safety contracting, level of care consultation, emergency contact notification)
Any referrals made and whether the client agreed to follow through
Your plan if the client does not follow through

Documenting safety concerns in SUD settings is not different from other mental health contexts, but the integration with SUD-specific risks (overdose risk following relapse after a period of abstinence, increased lethality due to tolerance changes) should be explicit in your clinical reasoning.

Common Documentation Mistakes in SUD Settings

Treating group notes as interchangeable. Every client in a group session needs an individualized note. Filing one collective note for all group members is a billing and liability problem.

Documenting UDS results without clinical context. A positive result with no follow-up documentation suggests the result was noted but not addressed clinically.

Vague relapse prevention plans. "Client will use coping skills when triggered" is not a relapse prevention plan. Be specific about what coping skills, what triggers, and what the client agreed to do.

Skipping motivational stage documentation. Insurance reviewers and utilization management teams use motivational stage to assess medical necessity for continued care. If you are not documenting it, you are making their job harder and your authorizations harder to obtain.

Characterizing mandated clients pejoratively. Words like "resistant," "uncooperative," and "in denial" are clinical conclusions, not observations. Support any characterization with specific, observable behaviors.

Not documenting MAT coordination. If your client is on buprenorphine or methadone and your notes do not reflect that, your record looks incomplete regardless of how good your clinical work is.